EDIT

Editas Medicine (EDIT)

Editas Medicine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EDIT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	05 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/01	05 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/01	05 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/05/23	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/05/10	19 : 00	GlobeNewswire Inc.	Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/05/09	05 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	21 : 29	IH Market News	U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices Fall	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20 : 00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results and Business Updates	NASDAQ:EDIT	Editas Medicine Inc
2024/05/02	20 : 00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events	NASDAQ:EDIT	Editas Medicine Inc
2024/05/01	21 : 00	GlobeNewswire Inc.	Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration	NASDAQ:EDIT	Editas Medicine Inc
2024/04/23	05 : 31	GlobeNewswire Inc.	Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/05	07 : 58	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	07 : 13	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	06 : 39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EDIT	Editas Medicine Inc
2024/02/28	21 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/02/28	21 : 00	GlobeNewswire Inc.	Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates	NASDAQ:EDIT	Editas Medicine Inc
2024/02/21	21 : 00	GlobeNewswire Inc.	Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events	NASDAQ:EDIT	Editas Medicine Inc
2024/02/14	22 : 40	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:EDIT	Editas Medicine Inc
2024/01/31	23 : 00	GlobeNewswire Inc.	Editas Medicine to Participate in Upcoming Investor Conferences	NASDAQ:EDIT	Editas Medicine Inc
2024/01/08	22 : 15	GlobeNewswire Inc.	Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference	NASDAQ:EDIT	Editas Medicine Inc
2024/01/03	21 : 00	GlobeNewswire Inc.	Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:EDIT	Editas Medicine Inc
2023/12/14	02 : 48	Dow Jones News	Editas Medicine Strikes License Deal With Vertex Pharmaceuticals -- Update	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23 : 49	Dow Jones News	Editas Medicine Strikes License Deal With Vertex Pharmaceuticals	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23 : 00	GlobeNewswire Inc.	Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9	NASDAQ:EDIT	Editas Medicine Inc